Unleashing the power of immunotherapy and targeted therapy combinations: Advancing cancer care or discovering unknown toxicities?
J Oncol Pharm Pract
; 27(4): 930-938, 2021 Jun.
Article
in En
| MEDLINE
| ID: mdl-33406979
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Therapy, Combination
/
Antineoplastic Agents, Immunological
/
Immunotherapy
/
Neoplasms
Type of study:
Clinical_trials
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
J Oncol Pharm Pract
Journal subject:
FARMACIA
Year:
2021
Type:
Article
Affiliation country:
United States